The Cigna GroupCI

Healthcare
Neutral

ASignal's systematic analysis rates CI as Neutral. The Cigna Group has a market cap of $73.74B, a P/E of 11.54, a 2.3% net margin, and 6.7% year-over-year revenue growth.

Reflects the latest available analysis · analyzed Aug 1, 2026

The case on CI

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Forward P/E of 8.33x below current P/E indicates earnings growth expectations
  • Strong free cash flow of $7.98B supports capital return and reinvestment capacity
  • Low PEG ratio of 0.89x suggests undervaluation relative to growth
  • EV/Revenue of 0.35x indicates attractive enterprise valuation relative to sales
  • ROE of 16.76% reflects solid capital efficiency
  • Dividend yield of 2.24% with sustainable 25.39% payout ratio
VS
Bear case
  • Negative MACD histogram and MACD below signal line suggest weakening momentum
  • Price trading below both SMA20 and SMA50, indicating short-term downtrend
  • Current ratio of 0.85x and quick ratio of 0.69x signal constrained liquidity
  • Low Reddit mentions (1) suggest limited retail interest or awareness

Key facts

Sector
Healthcare
Market cap
$73.74B
P/E ratio
11.54
Gross margin
9.1%
Net margin
2.3%
Rev growth YoY
6.7%
Price (Aug 1, 2026)
$279.05

Peers

Clustered with CI by analysis-profile similarity.

Subscriber-only

See the full verdict on CI

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes CI

Most investors never get a second opinion, let alone several. ASignal runs CI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

The Cigna Group (CI) Stock Analysis - ASignal rates it Neutral